ZA200903829B - Indole derivatives as S1P1 receptor agonists - Google Patents

Indole derivatives as S1P1 receptor agonists

Info

Publication number
ZA200903829B
ZA200903829B ZA200903829A ZA200903829A ZA200903829B ZA 200903829 B ZA200903829 B ZA 200903829B ZA 200903829 A ZA200903829 A ZA 200903829A ZA 200903829 A ZA200903829 A ZA 200903829A ZA 200903829 B ZA200903829 B ZA 200903829B
Authority
ZA
South Africa
Prior art keywords
receptor agonists
indole derivatives
indole
derivatives
agonists
Prior art date
Application number
ZA200903829A
Other languages
English (en)
Inventor
Mahmood Ahmed
James Myatt
David Norton
Dean Andrew Rivers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA200903829B publication Critical patent/ZA200903829B/xx

Links

ZA200903829A 2006-12-21 2009-06-02 Indole derivatives as S1P1 receptor agonists ZA200903829B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0625647A GB0625647D0 (en) 2006-12-21 2006-12-21 Compounds

Publications (1)

Publication Number Publication Date
ZA200903829B true ZA200903829B (en) 2010-04-28

Family

ID=37734704

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200903829A ZA200903829B (en) 2006-12-21 2009-06-02 Indole derivatives as S1P1 receptor agonists

Country Status (5)

Country Link
CN (1) CN101611033B (es)
ES (1) ES2365267T3 (es)
GB (1) GB0625647D0 (es)
UA (1) UA102508C2 (es)
ZA (1) ZA200903829B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3378854B1 (en) * 2010-01-27 2022-12-21 Arena Pharmaceuticals, Inc. Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
CN106977504A (zh) * 2017-04-06 2017-07-25 济南大学 一种1,2,4‑恶二唑衍生物、制备方法及其医药用途
CN115260173B (zh) * 2021-04-30 2024-08-30 厦门宝太生物科技股份有限公司 环戊烷并吲哚类支链酸衍生物及其制备方法和应用
CN116836157A (zh) * 2022-03-25 2023-10-03 星希尔生物科技(上海)有限公司 一种噁二唑衍生物及其制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060252741A1 (en) * 2003-05-15 2006-11-09 Colandrea Vincent J 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
CN1859908A (zh) * 2003-10-01 2006-11-08 默克公司 作为s1p受体激动剂的3,5－芳基、杂芳基或环烷基取代的－1,2,4－噁二唑类化合物

Also Published As

Publication number Publication date
GB0625647D0 (en) 2007-01-31
CN101611033A (zh) 2009-12-23
ES2365267T3 (es) 2011-09-27
UA102508C2 (ru) 2013-07-25
CN101611033B (zh) 2012-10-31

Similar Documents

Publication Publication Date Title
HK1140761A1 (en) Indole derivatives as s1p1 receptor agonists
IL192657A (en) Theophenic history as 1edg / 1p1s receptor agonists
HK1134294A1 (en) Thiophene derivatives as s1p1/edg1 receptor agonists
HK1135966A1 (en) Oxyindole derivatives as 5ht4 receptor agonists
ZA200806392B (en) Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as SIP receptor agonists
IL200911A0 (en) Amino-pyridine derivatives as s1p1/edg1 receptor agonists
IL198931A0 (en) Benzamide derivatives as ep4 receptor agonists
ZA200709087B (en) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
ZA200709086B (en) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
PT2003132E (pt) Derivados de oxadiazole como agonistas dos s1p1
EP2049520A4 (en) indole compounds
EP2079466A4 (en) SUBSTITUTED INDOLE COMPOUNDS
HK1149762A1 (en) Substituted indole derivatives
HK1110980A1 (en) Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
ZA200905265B (en) Indole derivatives
ZA200900843B (en) Indole compounds
ZA200903829B (en) Indole derivatives as S1P1 receptor agonists
ZA200709829B (en) Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists